Lawsuit Overview
Mar. 19, 2013 (Shareholders Foundation) - An investor in shares of The Dow Chemical Company (NYSE:DOW) filed a lawsuit against directors of The Dow Chemical Company over alleged breaches of fiduciary duties and other violations of law related to the Dow Chemical’s compensation for certain of its executive officers.
The plaintiff alleges that the defendants breached their fiduciary duties owed to NYSE:DOW stockholders in order to get millions in annual bonuses.
The Dow Chemical Company reported that its annual Total Revenue declined from $59.98 billion in 2011 to $56.78 billion in 2012 and its Net Income decreased from $2.74 billion in 2011 to $1.182 billion in 2012.
Shares of the Dow Chemical Company (NYSE:DOW) traded in 2011 as high as $40.99 per share and in 2012 as high as $35.31 per share.
On March 19, 2013, NYSE:DOW shares closed at $33.19.